Company intelligence / Profile preview

Bionical Emas

Paulsboro, New Jersey, United Statesbionicalemas.com ↗

Ownership: Private
Employees: ~250
Development stage: Commercial

Overview

Bionical Emas provides global Early Access Programs and Clinical Trial Supply services. It recently divested its clinical development arm to focus on these core areas. The company partners with leading pharma/biotech firms to enable patient access to investigational medicines and streamline global clinical trial logistics. No proprietary drug pipeline or direct clinical results.

Therapeutic areas: GastroenterologyOncologyImmunologyRare Diseases
Modalities: Small moleculeBiologic therapies
Industry: Contract Research Organization

Partnerships

Pharma Resources GmbH – exclusive global partnership for oncology injectables supply including Fluorouracil for clinical trials worldwide as of May 2025.

Beyond the preview

Go deeper on Bionical Emas.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bionical Emas.

Explore the full profile